Clinical Trials Browser

Phase 3 × Withdrawn × Injections × Clear all

NCT06301308 2024-04-24

A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial

Phase 3 Withdrawn

Urinary Bladder Neoplasms

NCT04288765 2021-07-09

Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma

Phase 3 Withdrawn

Multiple Myeloma